Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nuclear Myosin VI - a Therapeutic Target in Estrogen Receptor Positive Breast Cancer?

NCT03430024 is registered in ClinicalTrials.gov with Maidstone & Tunbridge Wells NHS Trust as lead sponsor.

NCT NCT03430024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03430024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nuclear Myosin VI - a Therapeutic Target in Estrogen Receptor Positive Breast Cancer?
Lead sponsor
Maidstone & Tunbridge Wells NHS Trust
Phase
Observational
Overall status
Unknown status
Start date
May 5, 2019
Completion date
December 31, 2020
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer